Persons engaged in national and international trade are required to draw up an annual summary statement indicating for each psychotropic substance or medicinal product containing it:
1° The quantities acquired on the national market ;
2° Quantities imported ;
3° Quantities sold on the national market;
4° Quantities exported;
5° Stocks.
This statement, which covers the previous calendar year, is sent to the Director General of the Agence nationale de sécurité du médicament et des produits de santé by 15 February at the latest.
The authorisation provided for in Article R. 5132-88 may require its holder to draw up and produce several summary statements during each calendar year.